Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients Assessment of the Correlation Between Body Mass Index and Recurrence Among Zoladex Treated Prostate Cancer Patients

NCT01020604 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01020604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients Assessment of the Correlation Between Body Mass Index and Recurrence Among Zoladex Treated Prostate Cancer Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
March 31, 2013
Enrollment
1,376 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, prostate cancer